ScholarIQanswers from OpenAlex & ORCID
Konstantinos Leventakos
ResearcherPublications, citations & collaboration network
Konstantinos Leventakos is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Konstantinos Leventakos have?
ScholarIQindexed works
Konstantinos Leventakos has 280 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Konstantinos Leventakos have?
ScholarIQcitation count
Konstantinos Leventakos has 4,121 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Konstantinos Leventakos?
ScholarIQh-index
Konstantinos Leventakos has an h-index of 27 in OpenAlex.
What is the i10-index of Konstantinos Leventakos?
ScholarIQi10-index
Konstantinos Leventakos has an i10-index of 56 in OpenAlex.
What is the ORCID of Konstantinos Leventakos?
ScholarIQorcid
The ORCID for Konstantinos Leventakos is on the source record.
What is the OpenAlex record for Konstantinos Leventakos?
ScholarIQopenalex
The OpenAlex for Konstantinos Leventakos is on the source record.
What are the most-cited papers on Konstantinos Leventakos?
ScholarIQmost cited works
Adagrasib in Non–Small-Cell Lung Cancer Harboring a <i> KRAS <sup>G12C</sup> </i> Mutation
Pasi A. Jänne, Gregory J. Riely, Shirish M. Gadgeel, Rebecca S. Heist, Sai‐Hong Ignatius Ou, Jose M. Pacheco, Melissa L. Johnson, Joshua K. Sabari, Konstantinos Leventakos, Edwin Yau, Lyudmila Bazhenova, Marcelo V. Negrão, Nathan A. Pennell, Jun Zhang, Kenna Anderes, Hirak Der‐Torossian, Thian Kheoh, Karen Velastegui, Xiaohong Yan, James G. Christensen, Richard C. Chao, Alexander I. Spira
Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years
Narjust Duma, Jesus Vera Aguilera, Jonas Paludo, Candace L. Haddox, Miguel González Vélez, Yucai Wang, Konstantinos Leventakos, Joleen M. Hubbard, Aaron S. Mansfield, Ronald S. Go, Alex A. Adjei
Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20‐year autopsy study
Russell E. Lewis, Lizebeth Cahyame‐Zuniga, Konstantinos Leventakos, Georgios Chamilos, Ronen Ben‐Ami, Pheroze Tamboli, Jeffrey J. Tarrand, Gerald P. Bodey, Mario A. Luna, Dimitrios P. Kontoyiannis
MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with <i>MTAP</i> -Deleted Cancer
Lars D. Engstrom, Ruth Aranda, Laura Waters, Krystal Moya, Vickie Bowcut, Laura Vegar, David Trinh, Allan Hebbert, Christopher R. Smith, Svitlana Kulyk, J. David Lawson, Leo He, Laura D. Hover, Julio Fernandez-Banet, Jill Hallin, Darin Vanderpool, David M. Briere, Alice Blaj, Matthew A. Marx, Jordi Rodón, Michael Offin, Kathryn C. Arbour, Melissa L. Johnson, David J. Kwiatkowski, Pasi A. Jänne, Candace L. Haddox, Kyriakos P. Papadopoulos, Jason T. Henry, Konstantinos Leventakos, James G. Christensen, Ronald Shazer, Peter Olson
Fitness and Virulence Costs of Candida albicans FKS1 Hot Spot Mutations Associated With Echinocandin Resistance
Ronen Ben‐Ami, Guillermo García‐Effrón, Russell E. Lewis, Soledad Gamarra, Konstantinos Leventakos, David S. Perlin, Dimitrios P. Kontoyiannis